07/28/2011
Ulla Davidsen, MD; Sune Haahr-Pedersen, MD, PhD; Rasmus Mogelvang, MD, PhD; Jan Bech, MD, PhD; Jan Kyst Madsen, MD, DMSc; Jan Skov Jensen, MD, PhD, DMSc; Allan Zeeberg Iversen, MD, PhD; Søren Galatius, MD, DMSc; Anders Galloe, MD, PhD; Ulrik Abildgaard, MD, DMSc; Peter Riis Hansen, MD, PhD, DMSc; Rikke Sorensen, MD, PhD; Steen Zabell Abildstrom, MD, PhD
Abstract: Objective. Use of drug-eluting stents (DES) in patients with ST-elevation myocardial infarction (STEMI) during routine primary percutaneous coronary intervention (pPCI) is controversial. Methods. From January 2004 to July 2008, a...
Abstract: Objective. Use of drug-eluting stents (DES) in patients with ST-elevation myocardial infarction (STEMI) during routine primary percutaneous coronary intervention (pPCI) is controversial. Methods. From January 2004 to July 2008, a...
Abstract: Objective. Use of...